Michael Tollini

Cooley advised Blue Owl Capital (NYSE: OWL), an asset manager redefining alternatives, on an up to $262.5 million term loan facility for ITM Isotope Technologies Munich SE, a radiopharmaceutical biotech company dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors.

Cooley advised Cerberus Capital Management, a global leader in alternative investing with approximately $65 billion in assets across complementary credit, real estate and private equity strategies, on its growth investment in Aquatech, a global leader in water technology and services for industrial and infrastructure markets.

Cooley advised PetLab Co., a rapidly growing independent pet supplement brand headquartered in London, on its majority stake sale to BC Partners, a top international investment firm.

Cooley advised Tempus AI (Nasdaq: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, on its $300 million incremental term loan and revolving credit commitments under its credit agreement with Ares Capital Corporation. Partners Addison Pierce and Michael Tollini led the Cooley team advising Tempus, which also included partner Eileen Marshall and associates JJ Meng, Stevie Yu and Yichao Zhang.

Cooley advised Vivid Seats in connection with a repricing of its $395 million term loan credit facility. Vivid Seats, which trades on the Nasdaq Global Select Market under the symbol SEAT, is an online ticket marketplace committed to becoming the ultimate partner for connecting fans to live events, artists and teams. Partner Addison Pierce led the Cooley team, which included Michael Tollini, Brad Goldberg, Amanda Weiss and Stevie Yu.